Stereotaxis Inc (FRA:RJR1)

Q2 2025 Stereotaxis Inc Earnings Call Transcript

Aug 7, 2025 / 08:30 PM GMT

Release Date Price: €1.88 (-1.05%)

Transcript 10-Q8-K

Key Points

Positve

Stereotaxis Inc (STXS) reported a significant revenue growth of 95% year-over-year for Q2 2025, reaching $8.8 million.
The company successfully completed the transfer to manufacturing of the Genesis X system, with the first commercial system expected to be installed in Europe soon.
FDA clearance of the Magic Sweep high-density mapping catheter marks a major milestone, enhancing the company's product portfolio and potential market impact.
Stereotaxis Inc (STXS) has a strong cash position with $18.8 million in cash and no debt following a recent equity financing.
The company is on track to achieve double-digit revenue growth for the full year 2025, with expectations of increased recurring revenue in the fourth quarter.

Negative

Gross margins remain impacted by acquisition-related accounting and low system production levels, with system gross margin at only 22%.
Operating expenses included $2.6 million in non-cash charges, impacting overall financial performance.
The company is still awaiting FDA approval for the Magic catheter in the US, with ongoing discussions on sterility, biocompatibility, and manufacturing practices.
Negative free cash flow for the second quarter was $3.7 million, indicating ongoing cash burn.
Administrative burdens in Europe are slowing the penetration of the Magic RF catheter, with only 30% of EU accounts having started using it.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

STXS.A - Stereotaxis Inc
Q2 2025 Stereotaxis Inc Earnings Call
Aug 07, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon.

Thank you for joining us for Ste Texas's 2nd quarter 2025 earnings conference call. Certain statements during the conference call and question and answer period to follow may may relate to future events, expectations, and as such constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1,995.

Such statements involve known and unknown risks, uncertainties, and other factors which may cost the actual results, performance, or achievements of the company in the future to be materially different from the statements that the company's executives may make today.

These risks are described in detail in our public filings with the Securities and Exchange

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.